These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4653122)

  • 21. What is quality of medicines?
    Doogue MP; Thynne TR
    Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 23. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 27. [Quality control of drugs--the contribution of pharmacy to drug safety standards. The historical development of the working group on drug quality control--pharmaceutical analysis of the German Pharmaceutical Society. 1].
    Göber B; Kny L; Langner A
    Pharm Unserer Zeit; 2000 May; 29(3):174-82. PubMed ID: 10881602
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of biological drugs: in-process controls with the LAL-assay.
    Ronneberger H
    Prog Clin Biol Res; 1987; 231():301-6. PubMed ID: 3588626
    [No Abstract]   [Full Text] [Related]  

  • 29. [Technical implications on the quality standard of new drugs].
    Uchiyama M
    Eisei Shikenjo Hokoku; 1995; (113):135-6. PubMed ID: 8717247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dossier of prescription preparations].
    Vanhalle G; Hanquin PJ
    J Pharm Belg; 1996; 51(5):237-84. PubMed ID: 9011601
    [No Abstract]   [Full Text] [Related]  

  • 31. Parenteral suspensions.
    Nash RA
    Bull Parenter Drug Assoc; 1972; 26(2):91-4. PubMed ID: 5012208
    [No Abstract]   [Full Text] [Related]  

  • 32. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 33. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug quality control--the contribution of pharmacy to drug safety. The historical development of the Working Group for Drug Control-Pharmaceutical Analysis of the German Pharmaceutical Society. 2].
    Göber B; Kny L; Langner A
    Pharm Unserer Zeit; 2000 Jul; 29(4):237-42. PubMed ID: 10969536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems in the production of pharmaceutical preparations].
    Dtsch Med J; 1972 Sep; 23(9):Suppl:XL. PubMed ID: 4640459
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of quality control methodology for new drugs.
    Wagner RL
    Bull Parenter Drug Assoc; 1972; 26(2):76-86. PubMed ID: 5012206
    [No Abstract]   [Full Text] [Related]  

  • 37. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1993 Nov; 50(11):2386-98. PubMed ID: 8266973
    [No Abstract]   [Full Text] [Related]  

  • 38. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 40. [Microbiological requirements for non-compulsory sterile drugs].
    Aureli P; Pasolini B
    Boll Chim Farm; 1985 Jun; 124(6):229-43. PubMed ID: 4063090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.